Natixis Advisors LLC increased its holdings in MetLife, Inc. (NYSE:MET - Free Report) by 5.2% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 266,316 shares of the financial services provider's stock after purchasing an additional 13,150 shares during the quarter. Natixis Advisors LLC's holdings in MetLife were worth $21,966,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also recently modified their holdings of MET. Abacus Planning Group Inc. increased its holdings in shares of MetLife by 1.0% during the 3rd quarter. Abacus Planning Group Inc. now owns 12,301 shares of the financial services provider's stock valued at $1,015,000 after purchasing an additional 127 shares in the last quarter. Financial Management Professionals Inc. increased its position in shares of MetLife by 2.0% in the 3rd quarter. Financial Management Professionals Inc. now owns 6,984 shares of the financial services provider's stock worth $576,000 after purchasing an additional 136 shares during the last quarter. Ameliora Wealth Management Ltd. lifted its stake in shares of MetLife by 1.7% in the 3rd quarter. Ameliora Wealth Management Ltd. now owns 8,548 shares of the financial services provider's stock worth $705,000 after acquiring an additional 139 shares during the period. Greenleaf Trust increased its stake in MetLife by 0.4% in the 3rd quarter. Greenleaf Trust now owns 31,393 shares of the financial services provider's stock valued at $2,589,000 after buying an additional 139 shares during the period. Finally, Forum Financial Management LP raised its stake in shares of MetLife by 1.0% in the 2nd quarter. Forum Financial Management LP now owns 13,729 shares of the financial services provider's stock valued at $964,000 after buying an additional 141 shares in the last quarter. Institutional investors own 89.81% of the company's stock.
Wall Street Analysts Forecast Growth
A number of research analysts recently commented on the company. Wells Fargo & Company boosted their price target on MetLife from $92.00 to $93.00 and gave the company an "overweight" rating in a research note on Tuesday, November 5th. Jefferies Financial Group increased their price target on MetLife from $89.00 to $95.00 and gave the company a "buy" rating in a report on Friday, September 27th. TD Cowen began coverage on MetLife in a report on Wednesday, October 9th. They set a "buy" rating and a $97.00 target price on the stock. StockNews.com raised MetLife from a "hold" rating to a "buy" rating in a research report on Tuesday, November 12th. Finally, Barclays reduced their price objective on MetLife from $91.00 to $90.00 and set an "overweight" rating on the stock in a research note on Thursday, October 31st. Fourteen research analysts have rated the stock with a buy rating, According to MarketBeat, the stock has a consensus rating of "Buy" and a consensus price target of $88.46.
Read Our Latest Stock Analysis on MetLife
MetLife Trading Down 0.6 %
MetLife stock traded down $0.54 during mid-day trading on Tuesday, hitting $82.83. 1,025,936 shares of the company's stock were exchanged, compared to its average volume of 3,313,909. MetLife, Inc. has a fifty-two week low of $61.85 and a fifty-two week high of $86.94. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $57.35 billion, a P/E ratio of 16.81, a PEG ratio of 0.76 and a beta of 1.05. The company's 50 day simple moving average is $81.76 and its 200-day simple moving average is $75.71.
MetLife Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Tuesday, November 5th will be issued a $0.545 dividend. The ex-dividend date is Tuesday, November 5th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.63%. MetLife's dividend payout ratio (DPR) is presently 43.95%.
MetLife Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.